Washington, DC 20006-5349
HELPLINE
Data from a positive phase 2/3 clinical trial evaluating the effectiveness of a drug for mesothelioma was just published in the Journal of the American…
Melina Marmarelis, MD, Thoracic Medical Oncologist, UPenn joins us for an interview about precision medicine for mesothelioma. She discusses biomarker information, such as histology (currently…
Hair loss, or alopecia, is often associated with cancer therapies and, in particular, with cytotoxic chemotherapy. While this side effect is most often temporary –…
Due to recent advances in cancer treatment, especially in the field of immunotherapy, chemotherapy treatment options for mesothelioma have taken a back seat. However, this…
This article aims to build on the Part 1 of this series. Out of necessity, mesothelioma patients more than other patient groups are savvy consumers…
UPDATE: Deadline extended to November 17 at 11:59 PM ET. Thanks to the generous support of our patients, families, caregivers, corporate supporters, and the many…
A group of patients joins the patient panel at the 2023 International Symposium on Malignant Mesothelioma to discuss their experiences of diagnosis, finding an expert…
Joseph George, RN, Memorial Sloan Kettering Cancer Center presents at the 2023 International Symposium on Malignant Mesothelioma on palliative symptom management in patients with mesothelioma. This is a recording of a session at the 2023 International Symposium on Malignant Mesothelioma. This symposium is made possible by our generous sponsors: Belluck and…
Making an impact on mesothelioma research, education, support and advocacy can include a variety of ways depending on a supporter’s comfort level and ability. Mackenzie Thomas and Carolyn Shields take us through some ideas. This is a recording of a session at the 2023 International Symposium on Malignant Mesothelioma. This…
Lawyers Joseph Belluck of Belluck & Fox, and Dawn Besserman of MRHFM discuss legal issues surrounding a mesothelioma diagnosis. Moderated by Cheryl Bruner. This is a recording of a session at the 2023 International Symposium on Malignant Mesothelioma. This symposium is made possible by our generous sponsors: Belluck and Fox, LLP; Maune…
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
